Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Occult Gastrointestinal Perforation in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer Receiving Combination Chemotherapy With Atezolizumab and Bevacizumab: Brief Report.

Occult Gastrointestinal Perforation in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical lung cancer Pubmed

Occult Gastrointestinal Perforation in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer Receiving Combination Chemotherapy With Atezolizumab and Bevacizumab: Brief Report.

Clinical lung cancer , Volume 21 (2): -5699 – Apr 2, 2021
Loading next page...
 
/lp/pubmed/occult-gastrointestinal-perforation-in-a-patient-with-egfr-mutant-non-MWiXgffDer

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1525-7304
eISSN
1938-0690
DOI
10.1016/j.cllc.2019.11.014
pmid
31864906

Abstract

Journal

Clinical lung cancerPubmed

Published: Apr 2, 2021

References